"With over 30 years of dedicated service to the Norwalk and Cerritos area, Dr. Cruz and her team of Nurse Practitioners (NPs) and caring clinical staff are committed to attend the health needs for you and your loved ones. Utilizing a comprehensive approach to health care, we pride ourselves on providing high-quality medical care, with a special focus on individualized patient needs."

During the past decade, Lucita M. Cruz, MD, Inc conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lucita M. Cruz, MD, Inc" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lucita M. Cruz, MD, Inc" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator and "Department of Health and Human Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Lucita M. Cruz, MD, Inc" are "Type 2 Diabetes" (3 trials), "Severe Hypertriglyceridemia" (2 trials), "Acute Gout" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Lucita M. Cruz, MD, Inc" in a lesser frequency.

Most popular intervention types in "Lucita M. Cruz, MD, Inc" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (3 trials), "Placebo" (3 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lucita M. Cruz, MD, Inc" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Lucita M. Cruz, MD, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Lucita M. Cruz, MD, Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lucita M. Cruz, MD, Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".